MGTX MeiraGTx Holdings plc
Price (delayed)
$4.25
Market cap
$275.82M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.4
Enterprise value
$262.36M
MeiraGTx is a vertically integrated, clinical stage gene therapy company with six programs in clinical development and a broad pipeline of preclinical and research programs. MeiraGTx has core capabilities in
Highlights
MeiraGTx Holdings's debt has decreased by 4% YoY
MGTX's EPS is up by 45% year-on-year but it is down by 20% since the previous quarter
The company's net income fell by 26% QoQ but it rose by 25% YoY
The company's gross profit has shrunk by 86% YoY and by 77% QoQ
The revenue has shrunk by 86% YoY and by 77% QoQ
Key stats
What are the main financial stats of MGTX
Market
Valuations
Earnings
Shares outstanding
64.9M
Market cap
$275.82M
Enterprise value
$262.36M
Price to earnings (P/E)
N/A
Price to book (P/B)
3.41
Price to sales (P/S)
279.47
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
267.99
Revenue
$979,000
EBIT
-$79.81M
EBITDA
-$65.92M
Free cash flow
-$21.53M
Per share
Balance sheet
Liquidity
EPS
-$1.4
Free cash flow per share
-$0.33
Book value per share
$1.24
Revenue per share
$0.02
TBVPS
$4.13
Total assets
$266.65M
Total liabilities
$186.61M
Debt
$87.57M
Equity
$80.04M
Working capital
$63.77M
Debt to equity
1.09
Current ratio
2.36
Quick ratio
2.18
Net debt/EBITDA
0.2
Margins
Efficiency
Dividend
EBITDA margin
-6,733.6%
Gross margin
100%
Net margin
-9,514.2%
Operating margin
-18,012.3%
Return on assets
-31.8%
Return on equity
-86.3%
Return on invested capital
-36.3%
Return on capital employed
-36.3%
Return on sales
-8,152.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MGTX stock price
How has the MeiraGTx Holdings stock price performed over time
Intraday
-0.47%
1 week
2.16%
1 month
0.47%
1 year
-24.78%
YTD
-39.46%
QTD
0.95%
Financial performance
How have MeiraGTx Holdings's revenue and profit performed over time
Revenue
$979,000
Gross profit
$979,000
Operating income
-$176.34M
Net income
-$93.14M
Gross margin
100%
Net margin
-9,514.2%
The company's gross profit has shrunk by 86% YoY and by 77% QoQ
The revenue has shrunk by 86% YoY and by 77% QoQ
MeiraGTx Holdings's operating income has decreased by 42% YoY and by 11% QoQ
The company's net income fell by 26% QoQ but it rose by 25% YoY
Growth
What is MeiraGTx Holdings's growth rate over time
Valuation
What is MeiraGTx Holdings stock price valuation
P/E
N/A
P/B
3.41
P/S
279.47
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
267.99
MGTX's EPS is up by 45% year-on-year but it is down by 20% since the previous quarter
MGTX's equity is down by 35% YoY and by 34% from the previous quarter
The stock's price to book (P/B) is 11% more than its 5-year quarterly average of 3.1 and 7% more than its last 4 quarters average of 3.2
The revenue has shrunk by 86% YoY and by 77% QoQ
Efficiency
How efficient is MeiraGTx Holdings business performance
MeiraGTx Holdings's return on equity has decreased by 38% QoQ but it has increased by 21% YoY
The ROIC fell by 36% QoQ but it rose by 30% YoY
MGTX's return on assets is down by 30% since the previous quarter but it is up by 22% year-on-year
Dividends
What is MGTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MGTX.
Financial health
How did MeiraGTx Holdings financials performed over time
MeiraGTx Holdings's total assets is 43% higher than its total liabilities
The company's current ratio fell by 25% QoQ but it rose by 19% YoY
The quick ratio has grown by 25% YoY but it has contracted by 21% from the previous quarter
MeiraGTx Holdings's debt is 9% higher than its equity
The company's debt to equity rose by 49% QoQ and by 47% YoY
MGTX's equity is down by 35% YoY and by 34% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.